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Abstract.
subcutaneous

BALB/cBYJ
mice were immunized
against larval Onchocerca volvulus by
injection of normal, irradiated, or freeze-thawâ€”killed Onchocerca sp. larvae.

The mice received challenge infections of 0. volvulus third-stage larva (L3) contained in
diffusion chambers implanted subcutaneously.
At two-weeks postinfection,
the diffusion
chambers were removed and larval survival was assessed. When mice were immunized a

single time with 35-kradâ€”irradiated or normal 0. volvulus L3, there was a significant re
duction in the survival of challenge parasites. However, there was little or no reduction in
challenge worm survival when mice were immunized a single time with freeze-thawâ€”killed
0. volvulus L3 or fourth-stage larva (L@j, or irradiated 0. lienalis L3. When a second dose
of freeze-thaw killed 0. volvulus L3 or irradiated 0. lienalis L3 was administered,
there was

a significant reduction in parasite survival in immunized
volvulus L4 or a combination

mice. Immunization

of L3 and L4 failed to confer protection.

with 0.

These results dem

onstrate that mice can be immunized against larval 0. volvulus and that diffusion chambers
arean efficient
method forstudyingprotective
immunity tothisparasite
ina mouse model.

Studies on the induction and mechanisms of

@

protective immunity to Onchocerca spp. have
focused largely on responses to microfilariae (ml).

large-scale study of protective immunity to 0.
volvulus due to the prohibitive
cost and strict
regulations associated with their use. Therefore,

It has been shown that mice can be immunized
against infection with mf of 0. lienalis by pre
vious sensitization with normal living
2Re

there is a need for small animal models to study
immune-mediated resistance to L3 of0. volvulus
and to screen antigens as potential vaccine can

sistance

didates.
All attempts

to infection

with

mf can

be passively

transferred with serum from immunized mice or
by transferring a combination of immune T and
B cells.3 Mice immunized against 0. lienalis mf
were also shown to be resistant to infection with
mfof 0. volvulus.4 While the study of protective
immunity to mf may be of importance in un
derstanding

the pathogenesis

of onchocerciasis,

the development ofvaccines against the infection
will depend on a thorough knowledge of immune
responses to the infective third-stage larvae (L3).5
Animal models available for studying immu

nity to the L3of 0. volvulus are extremely limited.
Natural

animal

reservoir

and mangabey

have been experimentally
vu/us L3.6@Â°Although

banal worms for immunologic
studies in both
natural and alternative host systems.'6' 1822 In

distinguish challenge worms from persisting
immunization
worms.

monkeys

infected with 0. vol

infections

spp. larvae

addition to ensuring accurate recovery of chal
lenge larvae, this method makes it possible to

hosts for this infection

have not been identified and only rare infections
of nonhuman primates in the wild have been
reported.6 Chimpanzees

to recover Onchocerca

from small laboratory animals following infec
tion have ai'
â€˜However, Onchocerca spp.
larvae contained in diffusion chambers can be
recovered from various rodent hosts for extend
ed periods of time.'4'7 Survival and develop
ment of 0. vo/vu/us L3 in diffusion chambers
implanted in mice were equivalent to that seen
in primates.'7 The diffusion chamber technique
has been used successfully to contain various fi

reach patency

in chimpanzees and mangabey monkeys, it is
unlikely that these animals could be used for
783

live

Vaccination against infection using radiation
attenuated parasites has been used successfully
against the filarial worms Brugia malayi,21'23'24
Dirofilaria immitis,20'25 B. pahangi,23'26'27 Acan
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thocheilonema
viteae,28 and Litomosoides
can
nii.29 Immunization
of mice with irradiated 0.
lienalis L3 significantly reduced challenge infec

radiated at different doses by exposure to x-rays
using an orthovoltage x-ray unit (Siemens, Er
langen, Germany). Fourth-stage larvae were pre

tions oflarvae contained within diffusion cham

pared by implanting

hers.'6 The bevels of protection

fusion

elicited with ir

radiated filarial vaccines were consistently higher
than those seen usingotherparasite

preparations;

however, the exact reasons for this superiority
are unclear.30 While the radiation dose used to
attenuate the immunizing parasites was a critical
factor, the optimal radiation dose varied de
pending upon the parasite system.
The objectives of this study were to demon
strate that protective immunity against 0. vol
vu/us larvae could be induced in a mouse model

and to determine which parasite components are
necessary

for that induction.

It was found that

mice can be immunized against larval 0. volvulus
using normal 0. volvulus L3or 0. volvulus L3that
were irradiated at a wide range of dosages. Vac
cination with dead 0. volvu/us L3 or irradiated

chambers

subcutaneously

containing

0.

in mice dif

volvulus

L3 for

nine days. It was previously demonstrated
that
0. volvu/us L3 molt to L4 3â€”7days after implan
tation in vivo in diffusion chambers.'7 Dead L@

or L4 were prepared for immunization by freez
ing and thawing larvae five times on dry ice and
in a 37Â°Cwater bath.
Experimental

protocol

Mice were immunized by injecting 50 larvae
subcutaneously
into the nape ofthe neck for the
primary immunization,
followed two weeks later

by 25 larvae for the second immunization,

unless

otherwise noted. Three weeks after the initial
immunization,
animals received challenge infec

tions consisting of 25 0. volvu/us L3 implanted

0. lienalis L3 was also effective in inducing im
munity when a booster dose was administered.

periments were terminated

However, preparations

allenge to allow sufficient time for challenge

containing fourth-stage

larva (L4) failed to confer protection.

subcutaneously

AND METHODS

chambers.

Ex

two weeks postch
L@

targets
17 Mice

for the immune
were

methoxyfiurane

killed

by

response

exsanguination

(Pitman-Moore

Inc.,

to at
under

Munde

lein, IL), diffusion chambers were removed, and

Animals
Male BALB/cByJ
Jackson Laboratories

diffusion

to develop into L4, thereby giving the host two
larval

MATERIALS

within

mice were obtained from
(Bar Harbor, ME). Mice

larvae were recovered. Actively motile larvae with
good structural integrity were counted as live and

were then fixed in 70% alcohol containing 5%

were between six and 12 weeks ofage at the start
of the experiment.

glycerine at 60Â°C.Larval lengths were measured

Antigen pnepanations

tional Institute ofMental

Cryopreserved
L3 were prepared in Liberia.
Briefly, pupae of Simulium yahense were cob
lected in the field and reared to adults in the
laboratory. The flies were fed on 0. volvulus

Statistical

infected donors and after seven days, L3 were
collected and cryopreserved in dimethyl sulf

using projected images in the Macmeasure image
analysis system (Research Services Branch, Na
Health, Bethesda, MD).

analysis

All data were analyzed by multivariate

general

linear hypothesis multifactorial analysis of van
ance using Systat 5.2 (Systat, Evanston, IL).

Probability values ofless than 0.05 were consid
oxideand sucroseusingBiocoobIIcomputerized ered significant. The percent reduction was cal
freezingequipment (FTS Systems Inc, Stone culated as follows: % Reduction = [(Mean con
Ridge,NY). Cryopreserved0. liena/is
L3 were trob mouse worm survival â€”Mean immunized
prepared as previously described. 16The L3 were mouse worm survival)Ã·Mean controlworm
survival] x 100.
defrosted as previously described'6â€•7and placed

in a 1:1 (v/v) mixture of National Cancer Insti
tute Tissue Culture Medium 135 and Iscove's
modified Dulbecco's media containing 100 U/mb
of penicillin/streptomycin
and 10 @ig/ml
ofgen

tamicin (Sigma, St. Louis, MO). Larvae were ir

RESULTS

Onchocenca

volvulus

L3 were x-irradiated

in

doses ranging from 5 to 85 krad and implanted
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LARVAL
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T@nii I
In vivo survival and devdopment ofx-irradiated Onchocerca volvulus infective third-stage larvae (L@)contained
in diffusion chambers that were implanted in micefor two weeks
live
recovery
(mean Â±SD)No.

of

Radiation
L@0324
dose (krad)No.

mice%

of

wormsLangth,

@im

L@%

(mean Â±SD)tStage%

L,/L@%

Â±1415509
86740535323Â±816478Â±660257515324Â±1414536Â±7114434325321Â±1312595Â±490010035328Â±2413496Â±612346314
Â±

Â±38470
580633755236Â±2814454Â±707504365327Â±612488Â±678672575312Â±148576Â±991338508526Â±33472Â±1906733
Â±

e Larvae that had formed the fourth-stage (L,) cuticle, but had not yet shed the L, cuticle, were classified as L,/I,,..

tLengthofL,

â€”497Â±96Mm.

in diffusion chambers in naive mice to assess the
development of radiation-attenuated
worms in
vivo. After two weeks, the diffusion chambers
were removed and larval survival and devel
opment were assessed. Larval survival of ap

had completed the molt to L4, while approxi
mately one-quarter of the surviving 35-kradâ€”ir

proximately

the L4 cuticle but had not yet completed the molt
to L4 (L3/L4) or they had successfully molted to
the L4 (Table 1).

25% was found in all groups, except

for larvae irradiated with 75 and 85 krad, for
which survival rates decreased to 12% and 6%,
respectively (Table 1). The lengths of recovered
worms were not significantly different among

groups; however, the percentage of larvae com
pleting the molt to L4 varied. By two weeks after
implantation,
all worms irradiated with 25 had

T@rn@n
2

radiated

larvae remained

of the irradiation
recovered

L3. Overall,

regardless

dose, the majority of larvae

after two weeks had either synthesized

Onchocerca volvulus L3 were x-irradiated in
dosages ranging from 5 to 85 had and were then
used to vaccinate mice using a single immuni
zation of 50 L3 per mouse. Immunization
re
sulted in reductionsin challenge parasite survival
ranging from 34% to 82% in all groups of im
munized mice (Table 2, experiment
1). The
greatest reduction was seen in mice vaccinated

Effect ofimmunization ofBALB/cBYJ mice with On
chocerca vobvulus inftctive third-stage larvae (L@), with 35-hadâ€”irradiated L3, while the least re
x-irradiated at various dosages, on the survival of duction was found with 25-had-irradiated
L3
challenge larvae implanted in diffusion chambers
vaccination. Mice were then immunized with ci
subcutaneously

ther 25-, 35-, or 45-hadâ€”irradiated larvae. Sig
nificant

Dose
ofi@
ofrecoveryreduc

SD)tionExperiment

per L,mice(mean

1Control
5
15
25
35
45
55
65
75

39*Experiment 855

< 0.05.

in challenge

larval

survival

groups

(Table 2, experiment
2). Because the 35-had
irradiated L3 immunization
consistently induced

Â±

5

Â±11
18Â±12

53@

a significant level of protective immunity, this

5
3
5
4
5
3
5

13Â±2
25Â±12
7Â±7
21Â±5
14Â±11
16Â±11
18Â±5

66
34
82*
45*
63*
58*
53*

immunization

538 23Â±7â€”

25

5

Â±8
22Â±8

35

5

14Â±9

455

534

2Control

74*eP

reductions

was observed in all of the immunized

live%(krad)No.
ation%

9Â±9â€”

protocol

was chosen

needed to confer a significant
35*

59*

for further

study.
Mice were immunized with initial doses of 10â€”
150 35-hadâ€”irradiated L@,followed in some cases
by a second immunization of 25 irradiated L,
(Table 3). A minimum of dose of 25 L was
level of protection.

The greatest reduction in worm survival was seen
in mice receiving an initial dose of 50 irradiated
larvae, followed by a second dose of 25 L@,two
weeks

later.

Increasing

the

initial

immunizing
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T@nut3

T@rn@n
4

Determination of the optimal primary dose and the Effect ofimmunization ofmice with normal, irradiated,
effect of a booster inoculation on the induction of
and killed Onchocerca vobvulus inftctive third-stage
larvae (L@)and/orfourth-stage larvae (Li) and irra
protective immunity in mice by 35-kradâ€”irradiated
Onchocerca volvulus infrctive third-stage larvae
diated Onchocerca lienalis L3 on the survival of 0.
volvulus L3 implanted in diffusion chambers. Mice
(L.@)
were immunized either a single time or received a
live
booster immunization*
Primary

of

ductionControl
doseBooster

10
25
50
50
100
150â€”
30*eP

doseNo.

â€”
â€”
â€”

25
25
2511

re

recovery

mice%

(mean Â±SD)%

Treatment,
species, and

45Â±7

6

0

6
23Â±13
4
21Â±8
5
14Â±8
5
26Â±8
540Â±928Â±11â€”

43*
48*
65*
35*

stage of

immunizing
reduction0.
larvaeNo.

of
miceNo.

volvulusNormal
L38154t35kradL39
67tDeadL35

<0.05.

of
doses%

260t

161

67tDeadL4413DeadL3/L45
151

dose above 50 L3 did not result in a further re
duction in challenge worm survival (Table 3).
At the termination ofthe irradiated larvae vac
cine trials, surviving larvae were collected from
diffusion chambers

00.

and their lengths were deter

length between worms recovered from immu
nized animals compared with those collected from

control animals.

induce protection against larval 0. volvulus. Im
with a single dose of normal,

unir

radiated 0. volvulus L3 induced a significant level
of protection. Immunization with a single dose
of dead 0. volvulus L3 or 15-hadâ€”irradiated 0.
lienalis L3 had no significant effect on challenge
worm survival. However, when booster doses of

dead 0. volvulus L3 or 15-badâ€”irradiated 0.
lienalis L3 were given, there was a significant
decrease in challenge worm survival. Immuni
using killed 0. volvulus L4 or a combi

nation ofL3 and L4were not effective in inducing
protective immunity (Table 4).

217

91
C Data

are

the

combined

results

from

four

experiments;

42t
values

listed

are the percent reductions obtained when the immunized groups were
compared with the control group in a particular experiment.
tP

Various methods of vaccine preparation from
Onchocerca spp. larvae were compared with 35hadâ€”irradiated 0. volvulus L3 for their ability to

zations

20

31

L3l5krad5
lienalis

mined. There was no consistent difference in

munization

214

< 0.05.

20 bad was used to attenuate the immunizing
larvae, the immunizingworms
died prematurely;
immunization
with these larvae failed to protect

dogs against the infection. This finding suggests
that the development of immunizing larvae to
L4 or adult worms is a requirement for effective
immunization

successful

of dogs

immunization

against

D. immitis.

For

of rats against L. can

nii, immunizing larvae must be attenuated by
radiation dosages greater than 40 had. If im
munizing

L. caninii L3 were irradiated

with less

than 40 had, they failed to confer protection.29
Irradiation

with 40 had prevented

L3 from molt

ing to L4. This finding suggests that in the L.
caninii system, prolonged exposure to L3 is re
quired for the induction

ofprotective

immunity.

Therefore, to develop immunity against some

DISCUSSION

parasites,

such as D. immitis,

it is important

for

In the present study, radiation-attenuated lar
vae were chosen for initial attempts at immu

the host to be exposed to more than one stage,
whereas for others, such as L. caninii, prolonged

nization

exposure

of mice against

larval

0. volvulus be

cause of the successes of irradiated

vaccines

against filaria in the
20'21,23-29Dogs have
been protected against infection with D. immitis

by immunization with 20-hadâ€”irradiated L3.
This dose of radiation caused the larvae to de
velop into sterile, stunted adults.25 If greater than

to a single stage is crucial.

In the present experiments, protective im
munity was seen in mice vaccinated with irra
diated

L3, regardless

of the radiation

dose used

to attenuate the larvae. In vivo, irradiated
volvulus larvae in diffusion

chambers

0.

survived

and developed to approximately the same degree
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regardless of the radiation dosage used. These
findings suggest that for 0. volvulus, unlike the

examples mentioned above, the dose of radiation
used to irradiate immunizing larvae is not a crit
ical factor in determining whether a vaccine will
induce a significant level ofparasite killing. This
successful immunization

ofmice

with irradiated

larvae appears to conflict with a study in which

induced

chimpanzees

attenuated 0. volvulus L3or irradiated 0. lienalis
L3. The model developed in the present study
can be a valuable tool for the screening of anti
gens for use in vaccines against 0. volvulus.

immunized

with

45-hadâ€”irradi

ated 0. vo/vu/us failed to develop protective im
munity.3' The experimental protocols used in the
chimpanzee

study and in the present mouse study

differ in the timing and dosage of the immuni
zations, making comparisons between these two
studies difficult. The criterion used for vaccine
efficacy in the chimpanzee study was the absence
of mf in the skin of immunized animals. It is
possible that protective immunity would have
been recognized in the chimpanzee study if the
presence

or absence of live larvae or adults had

been used as the criteria for vaccine success.
Killed parasite

@

possible explanation for this finding is that there
was great variability in the lengths of the L3, as
has been previously reported.35 This variability
may have overshadowed any differences caused
by the immune response.
In conclusion, these studies demonstrate that
protective immunity to larval 0. volvu/us can be

vaccines

have induced

protec

tive immunity in other filarial
32.33In
the present experiments, a single injection of 50
killed 0. volvu/us L3 did not produce immunity
to challenge. However, two immunizations with
killed 0. volvu/us L3 were abbe to confer resis
tance to infection comparable with that seen with
irradiated larvae. Immunization
with killed L4,

however, did not induce protective immunity.
Therefore, exposure to larval excretory/secretory
antigens or L4-specific antigens does not appear
to be required for the development of protective
immunity

against larval 0. volvu/us in the mouse.

Induction ofprotective immunity was dependent
upon the presence of L3 antigens and the dose
and timing of the immunizations.
Immunization

of mice in the present

study

with irradiated 0. lienalis L3 was capable of pro
ducing a significant reduction in the survival of
challenge 0. volvulus larvae. The dose of irra
diation used on the immunizing 0. liena/is larvae
was based on the optimal dose found for ho
mologous immunization and challenge.'6 Cross
species protection between filarial parasite spe
cies has been demonstrated with Onchocerca spp.
mf' and Brugia spp. L3.33
Growth retardation
ofchallenge
larvaehasbeen

reported in studies of protective immunity in D.
viteae,'9 B. malayi,2'

and D. immitis.34

Immu

nity induced against 0. vo/vulus by 35-hadâ€”ir
radiated 0. volvulus L3 was not associated with
a decrease in the length of challenge worms. A

in mice using live, dead or radiation
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